Probal Banerjee

Probal Banerjee is a Professor at the College of Staten Island (CSI), focusing on cancer immunotherapy, neuropharmacology, and neurodevelopmental disorders. His research integrates targeted drug delivery systems (e.g., curcumin-antibody conjugates) to enhance cancer therapy and explores the role of serotonin signaling in sex-specific anxiety disorders. He also investigates PKCε’s role in autism using Fmr1 knockout mouse models.

Education:

• M.Sc., Jadavpur University, Kolkata, India
• Ph.D., Indian Institute of Science, Bangalore, India
• Postdoctoral training: Joseph Kennedy Mental Retardation Center, University of Chicago Hospital

Research Interests:

• Development of antibody-targeted curcumin conjugates for glioblastoma treatment
• Mechanisms linking serotonin 1A receptor signaling to female-specific anxiety
• Role of PKCε in AMPA receptor trafficking and autism-like behaviors in FXS mice

Publications: Over 97 peer-reviewed articles, with recent work emphasizing immune modulation in cancer and neurodevelopmental disorders. His 2023 study highlights the innate immune system’s role in tumor microenvironment dynamics.

Students and Collaborators:

• Current advisees include Jared Cafiero (PhD) and Shubhasmita Mohapatra (postdoc)
• Past students include Juliet Baidoo (2023), Tatyana Budylin (2019), and Alexandra Marsillo (2017)

Labs/Teams: Leads a multidisciplinary lab focused on translational research at the intersection of immunology, neuroscience, and oncology. Collaborates with institutions like the University of Chicago and Johns Hopkins Medical School.